339 related articles for article (PubMed ID: 23542077)
1. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
[TBL] [Abstract][Full Text] [Related]
2. The association of the MTHFR C677T polymorphism with inflammatory bowel diseases in the Israeli Jewish population: An example of genetic heterogeneity.
Karban A; Feldman T; Waterman M; Leiba R; Efrati E
Medicine (Baltimore); 2016 Dec; 95(51):e5611. PubMed ID: 28002332
[TBL] [Abstract][Full Text] [Related]
3. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
4. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
6. Association study of a polymorphism in clock gene PERIOD3 and risk of inflammatory bowel disease.
Mazzoccoli G; Palmieri O; Corritore G; Latiano T; Bossa F; Scimeca D; Biscaglia G; Valvano MR; D'Incà R; Cucchiara S; Stronati L; Annese V; Andriulli A; Latiano A
Chronobiol Int; 2012 Oct; 29(8):994-1003. PubMed ID: 22881285
[TBL] [Abstract][Full Text] [Related]
7. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
Saibeni S; Spina L; Virgilio T; Folcioni A; Borsi G; de Franchis R; Cugno M; Vecchi M
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase C677T mutation in patients with alopecia areata in Turkish population.
Kalkan G; Yigit S; Karakuş N; Ateş O; Bozkurt N; Ozdemir A; Pancar GŞ
Gene; 2013 Nov; 530(1):109-12. PubMed ID: 23954881
[TBL] [Abstract][Full Text] [Related]
10. Mutations in clotting factors and inflammatory bowel disease.
Bernstein CN; Sargent M; Vos HL; Rosendaal FR
Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
[TBL] [Abstract][Full Text] [Related]
11. Association of celiac disease genes with inflammatory bowel disease in Finnish and Swedish patients.
Parmar AS; Lappalainen M; Paavola-Sakki P; Halme L; Färkkilä M; Turunen U; Kontula K; Aromaa A; Salomaa V; Peltonen L; Halfvarson J; Törkvist L; D'Amato M; Saavalainen P; Einarsdottir E
Genes Immun; 2012 Sep; 13(6):474-80. PubMed ID: 22592522
[TBL] [Abstract][Full Text] [Related]
12. Investigation of JAK2, STAT3 and CCR6 polymorphisms and their gene-gene interactions in inflammatory bowel disease.
Polgar N; Csongei V; Szabo M; Zambo V; Melegh BI; Sumegi K; Nagy G; Tulassay Z; Melegh B
Int J Immunogenet; 2012 Jun; 39(3):247-52. PubMed ID: 22269120
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels and breast cancer susceptibility: a case-control study in Taiwan.
Chou YC; Wu MH; Yu JC; Lee MS; Yang T; Shih HL; Wu TY; Sun CA
Carcinogenesis; 2006 Nov; 27(11):2295-300. PubMed ID: 16777985
[TBL] [Abstract][Full Text] [Related]
15. Association of the 5,10-methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) polymorphisms in Korean patients with adult acute lymphoblastic leukemia.
Oh D; Kim NK; Jang MJ; Kim HC; Lee JH; Lee JA; Ahn MJ; Kim CS; Kim HS; Park S; Chio HS; Min YH;
Anticancer Res; 2007; 27(5A):3419-24. PubMed ID: 17970089
[TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
17. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
18. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.
Russell RK; Drummond HE; Nimmo ER; Anderson NH; Noble CL; Wilson DC; Gillett PM; McGrogan P; Hassan K; Weaver LT; Bisset WM; Mahdi G; Satsangi J
Gut; 2006 Aug; 55(8):1114-23. PubMed ID: 16469794
[TBL] [Abstract][Full Text] [Related]
20. Common PPARγ variants C161T and Pro12Ala are not associated with inflammatory bowel disease in an Australian cohort.
Hume GE; Fowler EV; Griffiths LR; Doecke JD; Radford-Smith GL
J Gastrointestin Liver Dis; 2012 Dec; 21(4):349-55. PubMed ID: 23256116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
